Related Experiment Video

Updated: May 31, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Translational approaches targeting the p53 pathway for anti-cancer therapy

Frank Essmann1, Klaus Schulze-Osthoff

  • 1Interfaculty Institute for Biochemistry and Comprehensive Cancer Center, University of Tübingen, Tübingen, Germany.

British Journal of Pharmacology
|July 2, 2011
PubMed

Insights

The p53 tumor suppressor is crucial for blocking cancer by inducing apoptosis or senescence. Reactivating p53 function is a key strategy in developing novel anti-cancer therapies for various cancer types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor protein is critical in preventing cancer by initiating apoptosis or senescence in response to cellular stress.
  • Inactivation of the p53 signaling pathway is a common event in human cancers, making it a significant target for therapeutic intervention.
  • Understanding the mechanisms of p53 inactivation is essential for developing effective p53-based cancer treatments.

Purpose of the Study:

  • To review recent advancements in modulating the p53 pathway for cancer therapy.
  • To outline current strategies for pharmacological intervention targeting p53.
  • To highlight the diverse approaches being investigated to restore p53 function in cancer cells.

Main Methods:

  • Gene therapy utilizing adenovirus vectors for p53-mutated tumors.
  • Development of small-molecule drugs to reactivate mutant or misfolded p53.
  • Engineering oncolytic viruses for selective replication in p53-deficient cancer cells.
  • Investigating MDM2-p53 interaction inhibitors to prevent p53 degradation.

Main Results:

  • Adenovirus-mediated wild-type p53 gene therapy is clinically applied in some regions.
  • Promising progress in developing drugs that can restore the function of aberrant p53.
  • Clinical trials are evaluating small-molecule inhibitors targeting the MDM2-p53 interaction.

Conclusions:

  • Restoring or enhancing p53 pathway function represents a promising therapeutic avenue for a broad spectrum of cancers.
  • Multiple strategies, including gene therapy, small-molecule drugs, and oncolytic viruses, are being explored to target p53.
  • Pharmacological modulation of the p53 pathway holds significant potential for future cancer treatment development.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.